In several types of malignancies, such as choriocarcinoma [16], glioma [17], prostate cancer [18], pancreatic carcinoma [19] and lung cancer [20], TFPI-2 has significantly demonstrated tumor-suppressive functions during tumor cell invasion, metastasis, apoptosis, proliferation and angiogenesis. Here, TFPI2 is linked to prostate carcinoma.